Abstract:Statement of problem. Strontium has been validated for potent bone-seeking and antiosteoporotic properties and elicits a potentially beneficial impact on implant osseointegration in patients with osteoporosis. However, the efficacy of strontium supplementation on improving new bone formation and implant osseointegration in the presence of osteoporotic bone is still unclear.Purpose. The purpose of this systematic review was to comprehensively assess the efficacy of strontium supplementation, encompassing oral intake and local delivery of strontium, on implant osseointegration in patients with osteoporosis.Material and methods. Searches on electronic databases (MEDLINE or PubMed, Web of Science, EBSCO, Embase, and Clinicaltrials.gov) and manual searches were conducted to identify relevant preclinical animal trials up to June 2020. The primary outcomes were the percentage of bone -implant contact and bone area; the secondary outcomes were quantitative parameters of biomechanical tests and microcomputed tomography (mCT).Results. Fourteen preclinical trials (1 rabbit, 1 sheep, and 12 rat), with a total of 404 ovariectomized animals and 798 implants, were eligible for analysis. The results revealed a significant 17.1% increase in bone-implant contact and 13.5% increase in bone area, favoring strontium supplementation despite considerable heterogeneity. Subgroup analyses of both bone-implant contact and bone area exhibited similar outcomes with low to moderate heterogeneity. Results of biomechanical and mCT tests showed that strontium-enriched implantation tended to optimize the mechanical strength and microarchitecture of newly formed bone despite moderate to generally high heterogeneity.Conclusions. Based on the available preclinical evidence, strontium supplementation, including local and systemic delivery, showed promising results for enhancing implant osseointegration in the presence of osteoporosis during 4 to 12 weeks of healing. Future well-designed standardized studies are necessary to validate the efficacy and safety of strontium supplementation and to establish a standard methodology for incorporating Sr into implant surfaces in a clinical setting. (J Prosthet Dent 2022;128:341-9)

Intermittent administration of human parathyroid hormone (1-34) increases fixation of strontium-doped hydroxyapatite coating titanium implants via electrochemical deposition in ovariectomized rat femur.

Strontium-incorporated Titanium Implant Surface Treated by Hydrothermal Reactions Promotes Early Bone Osseointegration in Osteoporotic Rabbits

The effect of strontium-substituted hydroxyapatite coating on implant fixation in ovariectomized rats.

Intermittent Administration of Parathyroid Hormone [1-34] Prevents Particle-Induced Periprosthetic Osteolysis in a Rat Model.

The Effects of Combined Human Parathyroid Hormone (1-34) and Simvastatin Treatment on Osseous Integration of Hydroxyapatite-Coated Titanium Implants in the Femur of Ovariectomized Rats

Efficacy of strontium supplementation on implant osseointegration under osteoporotic conditions: A systematic review

A comparative study of strontium-substituted hydroxyapatite coating on implant’s osseointegration for osteopenic rats

Strontium-incorporated titanium implant surfaces treated by hydrothermal treatment enhance rapid osseointegration in diabetes: A preclinical vivo experimental study

Biomechanical and Morphometric Evaluation of a Strontium-Incorporated Implant and Four Commercially Available Implants: A Study in Rabbits

Effect of Strontium-Substituted Nanohydroxyapatite Coating of Porous Implant Surfaces on Implant Osseointegration in a Rabbit Model.

A Comparative Study of Zinc, Magnesium, Strontium-Incorporated Hydroxyapatite-Coated Titanium Implants for Osseointegration of Osteopenic Rats.

The Effects of Combined Human Parathyroid Hormone (1–34) and Simvastatin Treatment on the Interface of Hydroxyapatite-Coated Titanium Rods Implanted into Osteopenic Rats Femurs

Effects of Combined Human Parathyroid Hormone (1–34) and Menaquinone-4 Treatment on the Interface of Hydroxyapatite-Coated Titanium Implants in the Femur of Osteoporotic Rats

Cancellous Bone Response to Strontium-Doped Hydroxyapatite in Osteoporotic Rats

Effects of Sequential Treatment with Intermittent Parathyroid Hormone and Zoledronic Acid on Particle-Induced Implant Loosening: Evidence from a Rat Model

Fluorescence Microscopic Analysis of Bone Osseointegration of Strontium-Substituted Hydroxyapatite Implants.

Effects of Strontium Ranelate on Osseointegration of Titanium Implant in Osteoporotic Rats

A dual-functional strontium-decorated titanium implants that guides the immune response for osseointegration of osteoporotic rats

Effect of Thin Nano-Hydroxyapatite Coating on Implant Osseointegration in Ovariectomized Rats

Improvement of osseointegration of titanium dental implant surfaces modified with strontium-substituted hydroxyapatite

Parathyroid hormone enhances gap healing and osseointegration in orthopedic porous coated titanium implants: a correlative micro-computed tomographic, histomorphometric and biomechanical analysis